Andrew Merken discusses Polsinelli’s multidisciplinary approach to supporting life sciences companies throughout their growth, from formation and financing to commercialization, strategic transactions and exit. He highlights recent work involving strategic collaborations and capital markets transactions as examples of how integrated legal counsel can help companies navigate pivotal stages of development. Merken also addresses continued uncertainty in life sciences dealmaking, noting that financing challenges, regulatory headwinds and investor efforts to reduce risk are requiring companies to remain flexible and carefully evaluate their paths to growth.